These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1341 related articles for article (PubMed ID: 17097736)

  • 1. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
    Bengtsson B; Leske MC; Hyman L; Heijl A;
    Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of long-term progression in the early manifest glaucoma trial.
    Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z;
    Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disc hemorrhages and treatment in the early manifest glaucoma trial.
    Bengtsson B; Leske MC; Yang Z; Heijl A;
    Ophthalmology; 2008 Nov; 115(11):2044-8. PubMed ID: 18692244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.
    Nouri-Mahdavi K; Hoffman D; Coleman AL; Liu G; Li G; Gaasterland D; Caprioli J;
    Ophthalmology; 2004 Sep; 111(9):1627-35. PubMed ID: 15350314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optic disc and visual field changes after trabeculectomy.
    Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A;
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial.
    Heijl A; Leske MC; Hyman L; Yang Z; Bengtsson B;
    Acta Ophthalmol; 2011 Dec; 89(8):749-54. PubMed ID: 20236252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between intraocular pressure level and optic disc changes in high-tension glaucoma suspects.
    Tanito M; Itai N; Dong J; Ohira A; Chihara E
    Ophthalmology; 2003 May; 110(5):915-21. PubMed ID: 12750089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silent cerebral infarct and visual field progression in newly diagnosed normal-tension glaucoma: a cohort study.
    Leung DY; Tham CC; Li FC; Kwong YY; Chi SC; Lam DS
    Ophthalmology; 2009 Jul; 116(7):1250-6. PubMed ID: 19481813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between intraocular pressure variation and glaucoma progression: data from a United States chart review.
    Lee PP; Walt JW; Rosenblatt LC; Siegartel LR; Stern LS;
    Am J Ophthalmol; 2007 Dec; 144(6):901-907. PubMed ID: 17919446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-Zone parapapillary atrophy and the velocity of glaucoma progression.
    Teng CC; De Moraes CG; Prata TS; Tello C; Ritch R; Liebmann JM
    Ophthalmology; 2010 May; 117(5):909-15. PubMed ID: 20132988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and vision-related quality of life in the early manifest glaucoma trial.
    Hyman LG; Komaroff E; Heijl A; Bengtsson B; Leske MC;
    Ophthalmology; 2005 Sep; 112(9):1505-13. PubMed ID: 16019074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
    Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
    Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients.
    Heijl A; Bengtsson B; Chauhan BC; Lieberman MF; Cunliffe I; Hyman L; Leske MC
    Ophthalmology; 2008 Sep; 115(9):1557-65. PubMed ID: 18378317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of progression of visual field damage to postural changes in intraocular pressure in patients with normal-tension glaucoma.
    Kiuchi T; Motoyama Y; Oshika T
    Ophthalmology; 2006 Dec; 113(12):2150-5. PubMed ID: 16996611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of intraocular pressure reduction on perimetric variability in glaucomatous eyes.
    Fogagnolo P; McNaught A; Centofanti M; Rossetti L; Orzalesi N
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4557-63. PubMed ID: 17898278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the intervisit intraocular pressure fluctuation after 180 and 360 degrees of selective laser trabeculoplasty (SLT) as a primary therapy in primary open angle glaucoma and ocular hypertension.
    Prasad N; Murthy S; Dagianis JJ; Latina MA
    J Glaucoma; 2009 Feb; 18(2):157-60. PubMed ID: 19225355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The singapore 5-Fluorouracil trabeculectomy study: effects on intraocular pressure control and disease progression at 3 years.
    Wong TT; Khaw PT; Aung T; Foster PJ; Htoon HM; Oen FT; Gazzard G; Husain R; Devereux JG; Minassian D; Tan SB; Chew PT; Seah SK
    Ophthalmology; 2009 Feb; 116(2):175-84. PubMed ID: 19187822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.